These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22055553)

  • 1. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses.
    Moore AR; Straube S; Eccleston C; Derry S; Aldington D; Wiffen P; Bell RF; Hamunen K; Phillips C; McQuay H
    Pain; 2012 Feb; 153(2):265-268. PubMed ID: 22055553
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses.
    Palmer RH
    Pain; 2012 Jul; 153(7):1541. PubMed ID: 22657399
    [No Abstract]   [Full Text] [Related]  

  • 3. Validity of enriched enrollment, randomized withdrawal trials.
    Ruan X; Kaye AD
    Pain; 2016 Jan; 157(1):280. PubMed ID: 26681631
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal symptoms predict prescription opioid dependence in chronic pain patients.
    Coloma-Carmona A; Carballo JL; Rodríguez-Marín J; Pérez-Carbonell A
    Drug Alcohol Depend; 2019 Feb; 195():27-32. PubMed ID: 30562677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
    Edwards RR; Dworkin RH; Turk DC; Angst MS; Dionne R; Freeman R; Hansson P; Haroutounian S; Arendt-Nielsen L; Attal N; Baron R; Brell J; Bujanover S; Burke LB; Carr D; Chappell AS; Cowan P; Etropolski M; Fillingim RB; Gewandter JS; Katz NP; Kopecky EA; Markman JD; Nomikos G; Porter L; Rappaport BA; Rice ASC; Scavone JM; Scholz J; Simon LS; Smith SM; Tobias J; Tockarshewsky T; Veasley C; Versavel M; Wasan AD; Wen W; Yarnitsky D
    Pain; 2016 Sep; 157(9):1851-1871. PubMed ID: 27152687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting.
    Moore RA; Wiffen PJ; Eccleston C; Derry S; Baron R; Bell RF; Furlan AD; Gilron I; Haroutounian S; Katz NP; Lipman AG; Morley S; Peloso PM; Quessy SN; Seers K; Strassels SA; Straube S
    Pain; 2015 Aug; 156(8):1382-1395. PubMed ID: 25985142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cut-points for the measurement of pain: the choice depends on what you want to study.
    Farrar JT
    Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in design and interpretation of chronic pain trials.
    Moore RA; Derry S; Wiffen PJ
    Br J Anaesth; 2013 Jul; 111(1):38-45. PubMed ID: 23794643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pain therapy: stepchild of geriatrics].
    Stiefelhagen P
    MMW Fortschr Med; 2013 May; 155(9):22-3. PubMed ID: 23951643
    [No Abstract]   [Full Text] [Related]  

  • 10. A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.
    Dworkin RH; Allen R; Kopko S; Lu Y; Turk DC; Burke LB; Desjardins P; Etropolski M; Hewitt DJ; Jayawardena S; Lin AH; Malamut R; Michel D; Ottinger J; Peloso P; Pucino F; Rappaport BA; Skljarevski V; St Peter D; Timinski S; West CR; Wilson HD
    Pain; 2013 Jan; 154(1):11-14. PubMed ID: 23218970
    [No Abstract]   [Full Text] [Related]  

  • 11. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Baron R; Bellamy N; Burke LB; Chappell A; Chartier K; Cleeland CS; Costello A; Cowan P; Dimitrova R; Ellenberg S; Farrar JT; French JA; Gilron I; Hertz S; Jadad AR; Jay GW; Kalliomäki J; Katz NP; Kerns RD; Manning DC; McDermott MP; McGrath PJ; Narayana A; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Reeve BB; Rhodes T; Sampaio C; Simpson DM; Stauffer JW; Stucki G; Tobias J; White RE; Witter J
    Pain; 2010 May; 149(2):177-193. PubMed ID: 20207481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In process].
    Schlesselmann E; Schottky H
    Pflege Z; 2016 Aug; 69(8):490-4. PubMed ID: 29414200
    [No Abstract]   [Full Text] [Related]  

  • 13. A snapshot and scorecard for analgesic clinical trials for chronic pain: the RReACT database.
    Greene K; Dworkin RH; Rowbotham MC
    Pain; 2012 Sep; 153(9):1794-1797. PubMed ID: 22795917
    [No Abstract]   [Full Text] [Related]  

  • 14. Pain measurement and critical review of analgesic trials: pain scores, functional pain measurements, limits and bias of clinical trials.
    Lemoine A; Martinez V; Bonnet F
    Best Pract Res Clin Anaesthesiol; 2019 Sep; 33(3):287-292. PubMed ID: 31785714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of drug level testing in the assessment of chronic pain syndromes].
    Wolff D
    Versicherungsmedizin; 2013 Mar; 65(1):24-5. PubMed ID: 23593810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.
    Ney JP; Devine EB; Watanabe JH; Sullivan SD
    Pain Med; 2013 May; 14(5):706-19. PubMed ID: 23691937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Reasoning: A 62-year-old woman with bizarre behavior and recurrent episodes of behavioral arrest.
    Briglia H; Kohler S; Langer JE
    Neurology; 2016 Feb; 86(7):e62-5. PubMed ID: 26880814
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment.
    Edwards RA; Bonfanti G; Grugni R; Manca L; Parsons B; Alexander J
    Adv Ther; 2018 Oct; 35(10):1585-1597. PubMed ID: 30206821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sore thing.
    Nature; 2015 Feb; 518(7540):456. PubMed ID: 25719627
    [No Abstract]   [Full Text] [Related]  

  • 20. How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence.
    Ferrari M
    Cephalalgia; 1999 Mar; 19 Suppl 23():2-4; discussion 4-8. PubMed ID: 10099848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.